Why Blue Cross Blue Shield is rolling back coverage of GLP-1 weight loss drugs in Massachusetts

Why Blue Cross Blue Shield is rolling back coverage of GLP-1 weight loss drugs in Massachusetts

Massachusetts' largest commercial health insurer is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for weight loss. The reason? Rising costs.

Hospitals Increasingly Filing Antitrust Suits Against Blue Cross and Blue Shield Carriers

Large hospitals and health systems have filed a spate of antitrust suits against various Blue Cross and Blue Shield (BCBS) carriers, including Elevance Health and Health Care Service Corp. These plaintiffs in the recent lawsuits are those health system giants that opted out of the $2.8 billion antitrust settlement that BCBS agreed to last fall. They had until March 29, 2025, to reject the settlement and file suit. The plaintiff health systems, w…